Healthcare & Life Sciences
Cellaigie
France
About
Cellaigie develops AI-designed peptides that target the mTOR pathway to induce cellular states that promote renewal, enhanced autophagy, and longevity.
Explore Cellaigie's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.